Figure 4From: Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancerCorrelations between SUV peak and clinical outcome (PFS and OS). The correlations are for day 4 (open circles) and day 7 (black squares). Correlation coefficients were not statistically significant for both PFS and OS, with r s of 0.64 (P = 0.139) at days 4 and 7, respectively. PFS, progression-free survival; OS, overall survival.Back to article page